In conclusion, Omega-3s act on inflammation throughout the body and offer significant potential for alleviating symptoms of immune system-related disorders.
Kostoglou-Athanassiou, I., Athanassiou, L., & Athanassiou, P. (2020). The effect of omega-3 fatty acids on rheumatoid arthritis. Mediterranean journal of rheumatology, 31(2), 190-194. Kang, J. X., & Weylandt, K. H. (2008). Modulation of inflammatory cytokines by omega-3 fatty acids. Lipids in Health and Disease, 133-143. Mori, T. A., & Beilin, L. J. (2004). Omega-3 fatty acids and inflammation. Current atherosclerosis reports, 6(6), 461-467. Calder, P. C. (2010). Omega-3 fatty acids and inflammatory processes. Nutrients, 2(3), 355-374. Simopoulos, A. P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. Journal of the American College of nutrition, 21(6), 495-505. Geusens, P., Wouters, C., Nijs, J., Jiang, Y., & Dequeker, J. (1994). Long‐term effect of omega‐3 fatty acid supplementation in active rheumatoid arthritis. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 37(6), 824-829. Cabré, E., Mañosa, M., & Gassull, M. A. (2012). Omega-3 fatty acids and inflammatory bowel diseases–a systematic review. British Journal of Nutrition, 107(S2), S240-S252. Giacobbe, J., Benoiton, B., Zunszain, P., Pariante, C. M., & Borsini, A. (2020). The anti-inflammatory role of omega-3 polyunsaturated fatty acids metabolites in pre-clinical models of psychiatric, neurodegenerative, and neurological disorders. Frontiers in Psychiatry, 11, 450833. Dyall, S. C., & Michael-Titus, A. T. (2008). Neurological benefits of omega-3 fatty acids. Neuromolecular medicine, 10(4), 219-235. Laye, S., Nadjar, A., Joffre, C., & Bazinet, R. P. (2018). Anti-inflammatory effects of omega-3 fatty acids in the brain: physiological mechanisms and relevance to pharmacology. Pharmacological reviews, 70(1), 12-38. Teitelbaum, J. E., & Walker, W. A. (2001). the role of omega 3 fatty acids in intestinal inflammation. The Journal of nutritional biochemistry, 12(1), 21-32.